Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Am J Med
3 Biochemistry (Mosc)
1 BMC Pediatr
1 Epidemiol Infect
1 J Immunol
29 J Infect
5 J Infect Dis
4 Lancet
1 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
1 PLoS Biol
1 PLoS Med
29 PLoS One
2 Proc Natl Acad Sci U S A
3 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. BERGES M, Foster K, Foster J, Martinez L, et al
    Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations.
    Am J Med. 2022;135:547-549.

  2. PHYO ZH, Harris CM, Singh A, Kotwal S, et al
    Utility of a Diagnostic Time-out to Evaluate an Atypical Pneumonia.
    Am J Med. 2021 Nov 20. pii: S0002-9343(21)00744.

    Biochemistry (Mosc)

  3. KARYAGINA AS, Gromov AV, Grunina TM, Lyaschuk AM, et al
    Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization.
    Biochemistry (Mosc). 2022;87:319-330.
    PubMed         Abstract available

    Variability of Mortality: Additional Information on Mortality and Morbidity Curves under Normal and Pathological Conditions [Commentary on the Article by A. G. Malygin "Programmed Risks of Death in Male Patients with Diabetes" Published in Biochemistr
    Biochemistry (Mosc). 2022;87:294-299.
    PubMed         Abstract available

  5. OZGERIS FB, Kocak OF, Kurt N, Parlak E, et al
    High Serum Progranulin Levels in COVID-19 Patients: A Pilot Study.
    Biochemistry (Mosc). 2022;87:207-214.
    PubMed         Abstract available

    BMC Pediatr

  6. GIVON-LAVI N, Danino D, van der Beek BA, Sharf A, et al
    Disproportionate reduction in respiratory vs. non-respiratory outpatient clinic visits and antibiotic use in children during the COVID-19 pandemic.
    BMC Pediatr. 2022;22:254.
    PubMed         Abstract available


  7. BANATVALA J, Muir P, Irving W, Zuckerman M, et al
    Clinical virology in the pandemic response-a missed opportunity.
    BMJ. 2022;377:o1168.

  8. KWAN R
    How Hong Kong's vaccination missteps led to the world's highest covid-19 death rate.
    BMJ. 2022;377:o1127.

    Covid-19: US passes one million deaths as mask mandates return.
    BMJ. 2022;377:o1147.

  10. AL-ORAIBI A, Woolf K, Nellums LB, Tarrant C, et al
    Caring for the carers: understanding long covid in our diverse healthcare workforce.
    BMJ. 2022;377:o1152.

  11. TAYLOR L
    Covid-19: True global death toll from pandemic is almost 15 million, says WHO.
    BMJ. 2022;377:o1144.

    Why covid vaccine studies are still needed.
    BMJ. 2022;377:o1135.

  13. MAHASE E
    Covid-19: Remdesivir has "small effect" against death or progression to ventilation, WHO trial finds.
    BMJ. 2022;377:o1118.

  14. URNER M, Barnett AG, Bassi GL, Brodie D, et al
    Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study.
    BMJ. 2022;377:e068723.
    PubMed         Abstract available

    Epidemiol Infect

  15. POKUTNAYA D, Loiacono MM, Booth H, Williams R, et al
    The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally-representative retrospective cohort study, 2010-2019.
    Epidemiol Infect. 2022 May 6:1-24. doi: 10.1017/S0950268822000838.

    J Immunol

  16. GAO X, Zhu B, Wu Y, Li C, et al
    TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis.
    J Immunol. 2022;208:1456-1466.
    PubMed         Abstract available

    J Infect

  17. RUBESHKUMAR P, John A, Narnaware M, M J, et al
    Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.

  18. WHITAKER HJ, Tsang RS, Byford R, Andrews NJ, et al
    Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups.
    J Infect. 2022 Jan 3. pii: S0163-4453(21)00664.
    PubMed         Abstract available

  19. XU Y, Gao R, Zhu G, Zhou S, et al
    Genetic variation of allergic disease is associated with the susceptibility to COVID-19.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00016.

  20. ZHANG Y, Jiang N, Qi W, Li T, et al
    Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations.
    J Infect. 2022 Jan 15. pii: S0163-4453(22)00017.

  21. ELFIKY AA, Ibrahim IM
    Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view.
    J Infect. 2022 Jan 18. pii: S0163-4453(22)00015.

  22. GAO R, Xu Y, Zhu G, Zhou S, et al
    Genetic variation associated with COVID-19 is also associated with endometrial cancer.
    J Infect. 2022 Jan 22. pii: S0163-4453(22)00026.

  23. MARIANI C, Borgonovo F, Capetti AF, Oreni L, et al
    Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
    J Infect. 2022;84:722-746.

  24. RANA MS, Usman MM, Alam MM, Ikram A, et al
    Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00027.

  25. JI G, Chen C, Zhou M, Wen W, et al
    Post-COVID-19 Fatigue among COVID-19 in patients discharged from hospital: A meta-analysis.
    J Infect. 2022 Jan 28. pii: S0163-4453(22)00031.

  26. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The LONG-COVID-EXP-CM multicenter study.
    J Infect. 2022;84:722-746.

  27. MATTIUZZI C, Lippi G
    COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00051.

  28. XU W, Tang J, Chen C, Wang C, et al
    Safety and Efficacy of the Covid-19 Vaccine in children andor adolescents: A meta-analysis.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00050.

  29. LI Z, Tao B, Hu Z, Yi Y, et al
    Effects of short-term ambient particulate matter exposure on the risk of severe COVID-19.
    J Infect. 2022 Feb 1. pii: S0163-4453(22)00052.
    PubMed         Abstract available

  30. KIVIT C, Groen K, Jongbloed M, Linssen C, et al
    An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00058.

  31. YANG G, Ren Z, Zou Y, Xu Q, et al
    Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: lessons from the "dynamic zero-COVID policy" in mainland China.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00141.

  32. RYAN P, Perez-Garcia F, Torres-Macho J, Bibiano C, et al
    Misdiagnosis rate of among negative COVID-19 patients in real-life with Panbio COVID-19 Antigen Rapid Test during 2021.
    J Infect. 2022 Mar 16. pii: S0163-4453(22)00139.

  33. XIANG B, Yang L, Ye Z, Ren T, et al
    Vaccination of Susceptible Animals Against SARS-CoV-2.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00131.

  34. BONNET B, Chabrolles H, Archimbaud C, Brebion A, et al
    Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00132.

  35. FANTINI J, Devaux CA, Yahi N, Frutos R, et al
    The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.
    J Infect. 2022 Mar 6. pii: S0163-4453(22)00129.

  36. AU WY, Ye C, Briner SL, Suarez GD, et al
    Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00123.

  37. PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
    The value of electrostatic potentials of the Spike Receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 Variants. of Concern.
    J Infect. 2022 Feb 23. pii: S0163-4453(22)00112.

  38. DE MICHELENA P, Torres I, Ramos-Garcia A, Gozalbes V, et al
    Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.
    J Infect. 2022 Feb 22. pii: S0163-4453(22)00110.

  39. TANG K, Wu X, Luo Y, Wei Z, et al
    Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00081.

  40. LIPPI G, Nocini R, Henry BM
    Is SARS-CoV-2 Omicron (B.1.1.529) variant causing different symptoms?
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00077.

  41. BLANCO I, Violan C, Suner C, Garcia-Prieto J, et al
    Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2022 Feb 13. pii: S0163-4453(22)00072.

  42. YADAV PD, Sapkal GN, Sahay RR, Potdar VA, et al
    Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns.
    J Infect. 2022 Feb 11. pii: S0163-4453(22)00070.

  43. ZHOU W, Zhong L, Tang X, Huang T, et al
    The early warning and monitoring of COVID-19 by using Baidu Search Index in China.
    J Infect. 2022 Feb 6. pii: S0163-4453(22)00063.

  44. LAZOR-BLANCHET C, Zygoura P, Dafni U, Lamoth F, et al
    Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
    J Infect. 2022 Feb 5. pii: S0163-4453(22)00062.

  45. WESTROP SJ, Whitaker HJ, Powell AA, Power L, et al
    Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
    J Infect. 2022 Feb 4. pii: S0163-4453(22)00055.
    PubMed         Abstract available

    J Infect Dis

  46. BAHL P, Doolan C, de Silva C, Chughtai AA, et al
    Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?
    J Infect Dis. 2022;225:1561-1568.
    PubMed         Abstract available

  47. MCLAUGHLIN JM, Khan F, Schmitt HJ, Agosti Y, et al
    Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2022;225:1100-1111.
    PubMed         Abstract available

  48. DIAZ-DIAZ A, Bunsow E, Garcia-Maurino C, Moore-Clingenpeel M, et al
    Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.
    J Infect Dis. 2022;225:912-923.
    PubMed         Abstract available

  49. ABARA WE, Gee J, Delorey M, Tun Y, et al
    Expected Rates of Select Adverse Events following Immunization for COVID-19 Vaccine Safety Monitoring.
    J Infect Dis. 2021 Dec 27. pii: 6484617. doi: 10.1093.
    PubMed         Abstract available

  50. HAN T, Park H, Jeong Y, Lee J, et al
    COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains.
    J Infect Dis. 2022;225:1554-1560.
    PubMed         Abstract available


    Long-Acting RSV Antibody Injection Protects Healthy Infants.
    JAMA. 2022;327:1539.


    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.

    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.

  54. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.

  55. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.

    MMWR Morb Mortal Wkly Rep

  56. PRASAD N, Derado G, Nanduri SA, Reses HE, et al
    Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:633-637.
    PubMed         Abstract available

    N Engl J Med

  57. ROSSLER A, Knabl L, von Laer D, Kimpel J, et al
    Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMc2201607.

  58. SULLIVAN DJ, Gebo KA, Shoham S, Bloch EM, et al
    Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2119657.
    PubMed         Abstract available

  59. REIS G, Silva EASM, Silva DCM, Thabane L, et al
    Effect of Early Treatment with Ivermectin among Patients with Covid-19.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2115869.
    PubMed         Abstract available

  60. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
    N Engl J Med. 2022 Apr 5. doi: 10.1056/NEJMoa2201570.
    PubMed         Abstract available

  61. ESTCOURT L, Callum J
    Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    N Engl J Med. 2022;386:1753-1754.

  62. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Need New Covid-19 Vaccines?
    N Engl J Med. 2022;386:e52.

    PLoS Biol

  63. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
    Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
    PLoS Biol. 2022;20:e3001609.
    PubMed         Abstract available

    PLoS Med

  64. WAINSTEIN M, MacDonald S, Fryer D, Young K, et al
    Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    PLoS Med. 2022;19:e1003969.
    PubMed         Abstract available

    PLoS One

  65. ABDISA DK, Jaleta DD, Feyisa JW, Kitila KM, et al
    Access to maternal health services during COVID-19 pandemic, re-examining the three delays among pregnant women in Ilubabor zone, southwest Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0268196.
    PubMed         Abstract available

  66. MUKHERJEE S, Jain T
    Impact of COVID-19 on the mobility patterns: An investigation of taxi trips in Chicago.
    PLoS One. 2022;17:e0267436.
    PubMed         Abstract available

  67. SOLANKI G, Wilkinson T, Bansal S, Shiba J, et al
    COVID-19 hospitalization and mortality and hospitalization-related utilization and expenditure: Analysis of a South African private health insured population.
    PLoS One. 2022;17:e0268025.
    PubMed         Abstract available

  68. FEDERICI S, Lepri A, Castellani Mencarelli A, Zingone E, et al
    The sexual experience of Italian adults during the COVID-19 lockdown.
    PLoS One. 2022;17:e0268079.
    PubMed         Abstract available

  69. ALDRETE-CORTEZ V, Bobadilla L, Tafoya SA, Gonzalez-Carpinteiro A, et al
    Infants prenatally exposed to SARS-CoV-2 show the absence of fidgety movements and are at higher risk for neurological disorders: A comparative study.
    PLoS One. 2022;17:e0267575.
    PubMed         Abstract available

  70. ELMEKATY EZI, Alibrahim R, Hassanin R, Eltaib S, et al
    Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study.
    PLoS One. 2022;17:e0267884.
    PubMed         Abstract available

  71. STARK J, Daniel A, Twardawski M
    Social disparities in students' intention to enter higher education during the COVID-19 pandemic.
    PLoS One. 2022;17:e0267978.
    PubMed         Abstract available

  72. HONG W, Park YK, Kim BO, Park SK, et al
    Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
    PLoS One. 2022;17:e0267645.
    PubMed         Abstract available

  73. KIM Y, Zhu L, Zhu H, Li X, et al
    Characterizing cancer and COVID-19 outcomes using electronic health records.
    PLoS One. 2022;17:e0267584.
    PubMed         Abstract available

  74. BURGESS RA, Kanu N, Matthews T, Mukotekwa O, et al
    Exploring experiences and impact of the COVID-19 pandemic on young racially minoritised people in the United Kingdom: A qualitative study.
    PLoS One. 2022;17:e0266504.
    PubMed         Abstract available

    Users' satisfaction levels about mHealth applications in post-Covid-19 times in Saudi Arabia.
    PLoS One. 2022;17:e0267002.
    PubMed         Abstract available

  76. ZHOU Y, Rahman MM, Khanam R
    The impact of the government response on pandemic control in the long run-A dynamic empirical analysis based on COVID-19.
    PLoS One. 2022;17:e0267232.
    PubMed         Abstract available

  77. GUILLEN M, Bardes Robles I, Bordera Cabrera E, Acebes Roldan X, et al
    Acute respiratory infection rates in primary care anticipate ICU bed occupancy during COVID-19 waves.
    PLoS One. 2022;17:e0267428.
    PubMed         Abstract available

  78. ASSI S, Arafat B, Abbas I, Evans K, et al
    Evaluation of portable near-infrared spectroscopy for authentication of mRNA based COVID-19 vaccines.
    PLoS One. 2022;17:e0267214.
    PubMed         Abstract available

  79. STOCKLI S, Spalti AK, Phillips J, Stoeckel F, et al
    Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment.
    PLoS One. 2022;17:e0266003.
    PubMed         Abstract available

  80. DAWOOD B, Tomita A, Ramlall S
    'Unheard,' 'uncared for' and 'unsupported': The mental health impact of Covid -19 on healthcare workers in KwaZulu-Natal Province, South Africa.
    PLoS One. 2022;17:e0266008.
    PubMed         Abstract available

  81. NORMANDIN L, Wong C, Dumez V, Malas K, et al
    Reducing social isolation during the COVID-19 pandemic: Assessing the contribution of courtesy phone calls by volunteers.
    PLoS One. 2022;17:e0266328.
    PubMed         Abstract available

  82. BELL C, Goss M, Birstler J, Temte E, et al
    Assessment of potential factors associated with the sensitivity and specificity of Sofia Influenza A+B Fluorescent Immunoassay in an ambulatory care setting.
    PLoS One. 2022;17:e0268279.
    PubMed         Abstract available

  83. KASO AW, Agero G, Hurissa Z, Kaso T, et al
    Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.
    PLoS One. 2022;17:e0268280.
    PubMed         Abstract available

  84. NOOR F, Saleem MH, Javed MR, Chen JT, et al
    Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding.
    PLoS One. 2022;17:e0263901.
    PubMed         Abstract available

  85. RAMANI S, Bahuguna M, Tiwari A, Shende S, et al
    Corona was scary, lockdown was worse: A mixed-methods study of community perceptions on COVID-19 from urban informal settlements of Mumbai.
    PLoS One. 2022;17:e0268133.
    PubMed         Abstract available

  86. HIJANO DR, Hoffman JM, Tang L, Schultz-Cherry SL, et al
    An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic.
    PLoS One. 2022;17:e0268237.
    PubMed         Abstract available

  87. DOERRE A, Doblhammer G
    The influence of gender on COVID-19 infections and mortality in Germany: Insights from age- and gender-specific modeling of contact rates, infections, and deaths in the early phase of the pandemic.
    PLoS One. 2022;17:e0268119.
    PubMed         Abstract available

  88. PALMA MA, Huseynov S, Nayga RM Jr
    Health versus income amid COVID-19: What do people value more?
    PLoS One. 2022;17:e0267004.
    PubMed         Abstract available

  89. BAKER H, Concannon S, So E
    Information sharing practices during the COVID-19 pandemic: A case study about face masks.
    PLoS One. 2022;17:e0268043.
    PubMed         Abstract available

  90. SCHOEBER JPH, Schlaghecke JM, Meuwissen BMJ, van Heertum M, et al
    Comprehensive analytical and clinical evaluation of a RNA extraction-free saliva-based molecular assay for SARS-CoV-2.
    PLoS One. 2022;17:e0268082.
    PubMed         Abstract available

  91. PARKS AL, Auerbach AD, Schnipper JL, Bertram A, et al
    Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
    PLoS One. 2022;17:e0266944.
    PubMed         Abstract available

  92. CAMPBELL HM, Murata AE, Conner TA, Fotieo G, et al
    Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and relationship with mortality among United States Veterans after testing positive for COVID-19.
    PLoS One. 2022;17:e0267462.
    PubMed         Abstract available

  93. KOSAK F, Schelhorn I, Wittmann M
    The subjective experience of time during the pandemic in Germany: The big slowdown.
    PLoS One. 2022;17:e0267709.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  94. DUCH R, Robinson TS, Clarke PM, Roope LSJ, et al
    Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
    Proc Natl Acad Sci U S A. 2022;119:e2201847119.

  95. SPRECO A, Schon T, Timpka T
    Corruption should be taken into account when considering COVID-19 vaccine allocation.
    Proc Natl Acad Sci U S A. 2022;119:e2122664119.


  96. LIU W, Lien YH, Lee PI, Chan TC, et al
    Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Vaccine. 2022 May 4. pii: S0264-410X(22)00358.
    PubMed         Abstract available

  97. BELLIZZI S, Panu Napodano CM, Pinto S, Pichierri G, et al
    COVID-19 and seasonal influenza: The potential 2021-22 "Twindemic".
    Vaccine. 2022 May 5. pii: S0264-410X(22)00531.

  98. YU Y, Ma YL, Luo S, Wang S, et al
    Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China.
    Vaccine. 2022 May 5. pii: S0264-410X(22)00532.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.